- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 239/69 - Benzenesulfonamido-pyrimidines
Patent holdings for IPC class C07D 239/69
Total number of patents in this class: 84
10-year publication summary
|
5
|
6
|
5
|
7
|
10
|
6
|
4
|
1
|
0
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Xenon Pharmaceuticals Inc. | 196 |
7 |
| Vertex Pharmaceuticals Incorporated | 1587 |
5 |
| ESSA Pharma Inc. | 35 |
5 |
| Eastern Virginia Medical School | 64 |
3 |
| The Regents of the University of California, Santa Cruz | 17 |
3 |
| Thomas Jefferson University | 552 |
3 |
| University of Dundee | 218 |
3 |
| ZaCh System S.p.A. | 23 |
3 |
| BASF SE | 21292 |
2 |
| Genentech, Inc. | 4101 |
2 |
| FUJIFILM Corporation | 30458 |
2 |
| ADAMA Agan Ltd. | 442 |
2 |
| Generics [UK] Limited | 108 |
2 |
| Genzyme Corporation | 1368 |
2 |
| Sanford-Burnham Medical Research Institute | 125 |
2 |
| The United States of America Department of Health | 2 |
2 |
| Novartis AG | 10300 |
1 |
| AstraZeneca AB | 2815 |
1 |
| AstraZeneca UK Limited | 532 |
1 |
| Massachusetts Institute of Technology | 10230 |
1 |
| Other owners | 32 |